Search

everythinglearnresearchcommunity

for

Search:↓

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Topical antiandrogens might treat skin issues like hair growth, balding, and acne, but finding effective treatments without side effects is challenging.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Minoxidil and finasteride effectively treat hair loss.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Sophora flavescens extract may help hair grow by affecting growth factors and blocking a hair-related enzyme.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.